Development of Mcl-1 inhibitors for cancer therapy
Author:
Funder
Research Council
Science Foundation Ireland
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference170 articles.
1. Regulation of tumour necrosis factor signalling: live or let die;Brenner;Nat. Rev. Immunol.,2015
2. Expanding the cancer arsenal with targeted therapies: disarmament of the antiapoptotic bcl-2 proteins by small molecules: miniperspective;Yap;J. Med. Chem.,2016
3. Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway;Roy;Br. J. Pharmacol.,2014
4. The BCL-2 protein family, BH3-mimetics and cancer therapy,;Delbridge;Cell Death Differ.,2015
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mixed Stereochemistry Macrocycle Acts as a Helix-Stabilizing Peptide N-Cap;Journal of the American Chemical Society;2024-08-25
2. Common and rare variant analyses reveal novel genetic factors underlying Idiopathic Pulmonary Fibrosis and shared aetiology with COVID-19;2024-08-17
3. Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity;ACS Omega;2024-06-13
4. Development of recombinant protein-based nanoparticle systems for inducing tumor cell apoptosis: In vitro evaluation of their cytotoxic and apoptotic effects on cancer cells;Journal of Drug Delivery Science and Technology;2024-05
5. MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1;Molecular & Cellular Toxicology;2024-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3